NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: Electromagnetic Network-Targeted Field (ENTF) Therapy for Stroke Recovery
TL;DR
ENTF therapy offers stroke survivors a 22% higher chance of disability freedom compared to sham treatment, providing a significant recovery advantage.
ENTF therapy uses electromagnetic pulses to stimulate specific brain networks, combined with physical therapy over 40-45 sessions, reducing disability in stroke survivors.
This therapy improves stroke recovery, enabling more survivors to return to daily activities and reducing long-term disability burdens on families and communities.
A portable brain stimulation therapy tripled disability-free outcomes in stroke patients, showing promise for at-home neurological rehabilitation.
Found this article helpful?
Share it with your network and spread the knowledge!
ENTF therapy is a treatment that stimulates specific interconnected brain networks related to motor movement, cognitive functions, and other activities using electromagnetic pulses, with the goal of reestablishing normal neural organization after stroke.
The therapy uses electromagnetic pulse patterns derived from studies in people without stroke to model and facilitate the reestablishment of normal network organization in brains that show electrical disorganization after stroke, which is associated with improved functional recovery.
An analysis of two small clinical trials found that ENTF therapy combined with physical therapy significantly reduced overall disability in stroke survivors after 90 days compared to those who received sham electromagnetic stimulation with physical therapy.
The research was led by Dr. Jeffrey L. Saver from UCLA and will be presented at the American Stroke Association's International Stroke Conference 2026 in New Orleans (Feb. 4-6, 2026).
Researchers analyzed combined data from two double-blind, randomized, controlled studies involving 124 moderately to severely disabled stroke survivors (65 received ENTF therapy, 59 received sham treatment) who were enrolled on average 14 days after their stroke.
All participants received 40-45 sessions of either ENTF therapy or sham treatment over 8-12 weeks, combined with physical therapy during stimulation sessions, beginning in the hospital and continuing with at-home treatments using portable kits.
While advances in stroke treatments have saved lives, many survivors still face disabilities preventing normal daily activities, and ENTF therapy represents a promising approach to address this ongoing challenge.
The study is a research abstract presented at a scientific meeting and is not peer-reviewed; findings are considered preliminary until published as a full manuscript in a peer-reviewed scientific journal.
The research examined the effects of ENTF therapy on reducing disability after ischemic stroke.
Participants were assessed for overall disability and their motor and cognitive abilities after three months of treatment, with the average modified Rankin Scale (mRS) score at enrollment being 3.9.
Curated from NewMediaWire
